Highlights Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Market Closed - Bombay S.E. Other stock markets 03:31:19 04/06/2024 pm IST			5-day change	1st Jan Change
1,241 ^INR	-3.85%		-4.15%	-8.51%

24/05	Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution	MT
16/05	Caplin Point Laboratories to Seek Acquisitions	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ex-dividend day for interim dividend	31/05	FA
Caplin Point Laboratories to Seek Acquisitions	16/05	CI
Caplin Point Laboratories Limited Declares an Interim Dividend for the Financial Year Ended March 31, 2024	16/05	CI
Caplin Point Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	16/05	CI
Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	06/05	MT
Caplin Point Laboratories Limited Receives Colombia's INVIMA Approval for Its Softgel Capsules Division At Puducherry	06/05	CI
Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	16/04	MT
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	28/03	CI
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	27/03	MT
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	27/03	CI
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02	CI
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	08/01	MT
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	08/01	MT
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11	CI
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	22/23/22	CI
Final dividend	14/23/14	FA
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	04/23/04	MT
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/23/07	CI
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	07/23/07	CI
Caplin Point Laboratories to Incorporate Step-Down Subsidiary in US	03/23/03	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Caplin Point Laboratories Limited

Equities

CAPLIPOINT

INE475E01026

Highlights

Filters